Your browser doesn't support javascript.
loading
Low serum testosterone is a predictor of high-grade disease in patients with prostate cancer.
Albuquerque, George A M Lins de; Guglielmetti, Giuliano B; Barbosa, João Arthur B A; Pontes, José; Fazoli, Arnaldo J C; Cordeiro, Maurício D; Coelho, Rafael F; Carvalho, Paulo Afonso de; Gallucci, Fábio P; Padovani, Guilherme P; Park, Rubens; Cury, José; Nonemacher, Henrique; Srougi, Miguel; Nahas, William C.
Afiliação
  • Albuquerque GAML; Assistant Physician, Urology Service, Hospital Universitário Getúlio Vargas/Universidade Federal do Amazonas (HUGV/UFAM), and Assistant Physician, Urology Service, Fundação Centro de Controle em Oncologia do Estado do Amazonas (FCECON), Manaus, AM, Brazil.
  • Guglielmetti GB; Assistant Physician, Urology Service, Instituto do Câncer do Estado de São Paulo (Icesp), Hospital das Clínicas, Faculdade de Medicina da Universidade de São Paulo (HC-FMUSP), São Paulo, SP, Brazil.
  • Barbosa JABA; Urology Resident Physcian, HC-FMUSP, São Paulo, SP, Brazil.
  • Pontes J; Assistant Physician, Urology Service, Instituto do Câncer do Estado de São Paulo (Icesp), Hospital das Clínicas, Faculdade de Medicina da Universidade de São Paulo (HC-FMUSP), São Paulo, SP, Brazil.
  • Fazoli AJC; Assistant Physician, Urology Service, Instituto do Câncer do Estado de São Paulo (Icesp), Hospital das Clínicas, Faculdade de Medicina da Universidade de São Paulo (HC-FMUSP), São Paulo, SP, Brazil.
  • Cordeiro MD; Assistant Physician, Urology Service, Instituto do Câncer do Estado de São Paulo (Icesp), Hospital das Clínicas, Faculdade de Medicina da Universidade de São Paulo (HC-FMUSP), São Paulo, SP, Brazil.
  • Coelho RF; Assistant Physician, Urology Service, Instituto do Câncer do Estado de São Paulo (Icesp), Hospital das Clínicas, Faculdade de Medicina da Universidade de São Paulo (HC-FMUSP), São Paulo, SP, Brazil.
  • Carvalho PA; Assistant Physician, Urology Service, Instituto do Câncer do Estado de São Paulo (Icesp), Hospital das Clínicas, Faculdade de Medicina da Universidade de São Paulo (HC-FMUSP), São Paulo, SP, Brazil.
  • Gallucci FP; Assistant Physician, Urology Service, Instituto do Câncer do Estado de São Paulo (Icesp), Hospital das Clínicas, Faculdade de Medicina da Universidade de São Paulo (HC-FMUSP), São Paulo, SP, Brazil.
  • Padovani GP; Assistant Physician, Urology Service, Instituto do Câncer do Estado de São Paulo (Icesp), Hospital das Clínicas, Faculdade de Medicina da Universidade de São Paulo (HC-FMUSP), São Paulo, SP, Brazil.
  • Park R; Assistant Physician, Urology Service, Instituto do Câncer do Estado de São Paulo (Icesp), Hospital das Clínicas, Faculdade de Medicina da Universidade de São Paulo (HC-FMUSP), São Paulo, SP, Brazil.
  • Cury J; MD Urologist, HC-FMUSP. Head of the Sexual Medicine Group, São Paulo, SP, Brazil.
  • Nonemacher H; Fellow in Urologic Oncology, Icesp, HC-FMUSP, São Paulo, SP, Brazil.
  • Srougi M; Full Professor of Urology, FMUSP, São Paulo, SP, Brazil.
  • Nahas WC; Full Professor of Urology, FMUSP, and Head of the Urologic Oncology Group at Icesp, São Paulo, SP, Brazil.
Rev Assoc Med Bras (1992) ; 63(8): 704-710, 2017 Aug.
Article em En | MEDLINE | ID: mdl-28977109
OBJECTIVE: To evaluate the relation between serum total testosterone (TT) and prostate cancer (PCa) grade and the effect of race and demographic characteristics on such association. METHOD: We analyzed 695 patients undergoing radical prostatectomy (RP), of whom 423 had serum TT collected. Patients were classified as having hypogonadism or eugonadism based on two thresholds of testosterone: threshold 1 (300 ng/dL) and threshold 2 (250 ng/dL). We evaluated the relation between TT levels and a Gleason score (GS) ≥ 7 in RP specimens. Outcomes were evaluated using univariate and multivariate analyses, accounting for race and other demographic predictors. RESULTS: Out of 423 patients, 37.8% had hypogonadism based on the threshold 1 and 23.9% based on the threshold 2. Patients with hypogonadism, in both thresholds, had a higher chance of GS ≥ 7 (OR 1.79, p=0.02 and OR 2.08, p=0.012, respectively). In the multivariate analysis, adjusted for age, TT, body mass index (BMI) and race, low TT (p=0.023) and age (p=0.002) were found to be independent risk factors for GS ≥ 7. Among Black individuals, low serum TT was a stronger predictor of high-grade disease compared to White men (p=0.02). CONCLUSION: Hypogonadism is independently associated to higher GS in localized PCa. The effect of this association is significantly more pronounced among Black men and could partly explain aggressive characteristics of PCa found in this race.
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Testosterona / Antígeno Prostático Específico / Hipogonadismo Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans / Male Idioma: En Revista: Rev Assoc Med Bras (1992) Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Brasil País de publicação: Brasil
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Testosterona / Antígeno Prostático Específico / Hipogonadismo Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans / Male Idioma: En Revista: Rev Assoc Med Bras (1992) Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Brasil País de publicação: Brasil